Commercial Milestone Payment definition

Commercial Milestone Payment has the meaning set forth in Section 8.3.
Commercial Milestone Payment has the meaning set forth in Section 4.3(a).
Commercial Milestone Payment shall have the meaning set forth in Section 6.3.

Examples of Commercial Milestone Payment in a sentence

  • Ideaya shall pay to Biocytogen the applicable Commercial Milestone Payment within [***] after the end of the applicable Calendar Year.

  • Annual Net Sales of all Royalty-Bearing Licensed Products in the Territory (in US$) Commercial Milestone Payment (in US$) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Total $300,000,000 Each Commercial Milestone Payment above is payable one time only, regardless of the number of times the corresponding event is achieved by the Licensed Products.


More Definitions of Commercial Milestone Payment

Commercial Milestone Payment has the meaning set forth in Section 10.4(a).
Commercial Milestone Payment has the meaning given to such term in the PadCo-Protiva License and Services Agreement.
Commercial Milestone Payment is defined in Section 6.3.
Commercial Milestone Payment means a payment required under the provisions of Section 8.5 hereof.
Commercial Milestone Payment means the payments to be made on the Commercial Milestone Events and as set out in Clause 13.5.1; Commercially Reasonable Efforts means, on a Party-by-Party basis, that level of efforts and resources required to carry out a particular task or obligation in an active and sustained manner, consistent with the general practice followed by the Party required to use such efforts in the exercise of its reasonable business discretion relating to other pharmaceutical products owned by it, or to which it has exclusive rights, which are of similar market potential at a similar stage in their development or product life, taking into account issues of patent coverage, safety and efficacy, product profile, the competitiveness of products in development and in the marketplace, supply chain management considerations, the proprietary position of the compound or product, the regulatory structure involved, the profitability of the applicable products (including pricing and reimbursement status achieved), and other relevant factors, including technical, legal, scientific and/or medical factors;
Commercial Milestone Payment is defined in Section 2.05(b).
Commercial Milestone Payment. 10.3.1 “Commercialization Cost Report” 10.4.2(a) “Commercialization Guidelines”` 3.5.2(b) “Commercialization Plan” 6.2.1 “Competitive Infringement” 12.10.1 “Continuing Party” 14.7.6(a)(ii) “Continuing Payment Term” 14.7.6(a)(iii) “Continuing Product” 14.7.6(a)(iv) “Continuing Product Payments” 14.7.6(a) “Controlling Party” 12.10.3(a)(i) “Co-Promotion” 1.119 “Core Data Sheet” 5.5.1(b) “Cost Reconciliation Report” 10.4.2(b) “Cost Reports” 10.4.2(a) “CTC” Recitals “Data Protection Laws” 1.11 “Development Cost Report” 10.4.2(a) “Development Milestone Event” 10.2.1 “Development Milestone Payment” 10.2.1 “Development Plan” 5.2.1 “Dispute” 16.8.1 “Distribution” 6.4.1 -27- [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED